Trademark: 87139638
Word
REESANZ
Status
Dead
Status Code
606
Status Date
Monday, August 31, 2020
Serial Number
87139638
Mark Type
4000
Filing Date
Tuesday, August 16, 2016
Published for Opposition
Tuesday, May 30, 2017
Abandoned Date
Monday, August 31, 2020

Trademark Owner History
Novartis AG - Owner At Publication

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Trademark Events
Aug 31, 2020
Abandonment Notice E-Mailed - No Use Statement Filed
Aug 31, 2020
Abandonment - No Use Statement Filed
Jan 24, 2020
Notice Of Approval Of Extension Request E-Mailed
Jan 23, 2020
Extension 5 Granted
Jan 20, 2020
Extension 5 Filed
Jan 23, 2020
Case Assigned To Intent To Use Paralegal
Jan 20, 2020
Teas Extension Received
Jul 16, 2019
Notice Of Approval Of Extension Request E-Mailed
Jul 12, 2019
Extension 4 Granted
Jul 12, 2019
Extension 4 Filed
Jul 12, 2019
Teas Extension Received
Jan 23, 2019
Notice Of Approval Of Extension Request E-Mailed
Jan 21, 2019
Extension 3 Granted
Jan 21, 2019
Extension 3 Filed
Jan 21, 2019
Teas Extension Received
Jul 17, 2018
Notice Of Approval Of Extension Request E-Mailed
Jul 14, 2018
Extension 2 Granted
Jul 14, 2018
Extension 2 Filed
Jul 14, 2018
Teas Extension Received
Jan 26, 2018
Notice Of Approval Of Extension Request E-Mailed
Jan 24, 2018
Extension 1 Granted
Jan 24, 2018
Extension 1 Filed
Jan 24, 2018
Teas Extension Received
Jul 25, 2017
Noa E-Mailed - Sou Required From Applicant
May 30, 2017
Official Gazette Publication Confirmation E-Mailed
May 30, 2017
Published For Opposition
May 10, 2017
Notification Of Notice Of Publication E-Mailed
Apr 26, 2017
Law Office Publication Review Completed
Apr 24, 2017
Approved For Pub - Principal Register
Apr 12, 2017
Teas/Email Correspondence Entered
Apr 12, 2017
Correspondence Received In Law Office
Apr 6, 2017
Assigned To Lie
Mar 23, 2017
Teas Response To Office Action Received
Sep 28, 2016
Notification Of Non-Final Action E-Mailed
Sep 28, 2016
Non-Final Action E-Mailed
Sep 28, 2016
Non-Final Action Written
Sep 27, 2016
Assigned To Examiner
Aug 19, 2016
New Application Office Supplied Data Entered In Tram
Aug 19, 2016
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24